Bettinetti G P
Boll Chim Farm. 1989 May;128(5):149-62.
As a consequence of the importance of solid drug substance characterization, analytical tools such as X-ray diffractometry (powder and single crystal methods) are usually employed in the pharmaceutical field. The diagnostic power of X-ray powder diffraction in identifying crystalline compounds, even in multicomponent mixtures, and in showing the non-crystalline ones, has brought about the usual characterization through the X-ray powder diffraction pattern of polymorphic, pseudopolymorphic, and amorphous drugs and of some drug-carrier systems such as solid dispersions, glass dispersions, solid surface dispersions, physical mixtures, eutectics, solid solutions, addition and inclusion compounds, etc. Moreover this technique is also used in the qualitative and quantitative analysis both of drug mixtures and dosage forms, and also in the study of relationships between crystal habit and technological characteristics of pharmaceutical formulations. Single crystal methods are employed for calculating the unit cell lenghts and angles, for indexing powder diffraction patterns, and for demonstrating the crystal and molecular structure of the drug. After a picture of the solid state properties and the X-ray characteristics, as well as of the interaction between X-rays and solid matter, the main pharmaceutical applications of X-ray diffraction are described.
由于固体药物特性表征的重要性,诸如X射线衍射法(粉末法和单晶法)等分析工具通常在制药领域中使用。X射线粉末衍射在鉴定结晶化合物(即使是多组分混合物中的结晶化合物)以及显示非结晶化合物方面的诊断能力,使得通常通过多晶型、假多晶型和无定形药物以及一些药物载体系统(如固体分散体、玻璃分散体、固体表面分散体、物理混合物、低共熔物、固溶体、加成化合物和包合物等)的X射线粉末衍射图谱来进行表征。此外,该技术还用于药物混合物和剂型的定性和定量分析,以及研究晶体习性与药物制剂工艺特性之间的关系。单晶法用于计算晶胞长度和角度、标定粉末衍射图谱以及确定药物的晶体和分子结构。在介绍了固态性质、X射线特性以及X射线与固体物质之间的相互作用之后,描述了X射线衍射在制药方面的主要应用。